Cargando…

Cutaneous Metastases from Thymic Carcinoma Primary Tumor: A Rare Case

Cutaneous metastases (CM) are neoplastic lesions of the skin originating from a primary tumor elsewhere. CM originating from primary thymic carcinoma is rare, and its incidence remains uncertain. A case of CM from thymic carcinoma in a 57-year-old man was reported. The patient complained about lumps...

Descripción completa

Detalles Bibliográficos
Autores principales: Sutedja, Eva Krishna, Rizqandaru, Trustia, Ruchiatan, Kartika, Sutedja, Endang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207123/
https://www.ncbi.nlm.nih.gov/pubmed/35734095
http://dx.doi.org/10.2147/IMCRJ.S369726
_version_ 1784729448690483200
author Sutedja, Eva Krishna
Rizqandaru, Trustia
Ruchiatan, Kartika
Sutedja, Endang
author_facet Sutedja, Eva Krishna
Rizqandaru, Trustia
Ruchiatan, Kartika
Sutedja, Endang
author_sort Sutedja, Eva Krishna
collection PubMed
description Cutaneous metastases (CM) are neoplastic lesions of the skin originating from a primary tumor elsewhere. CM originating from primary thymic carcinoma is rare, and its incidence remains uncertain. A case of CM from thymic carcinoma in a 57-year-old man was reported. The patient complained about lumps on the skin of the chest, right shoulder and neck that appeared eleven months before the diagnosis of thymic carcinoma was established. Physical examination revealed tumors on the chest, right shoulder and neck. Histopathological examination results were consistent with CM. An immunohistochemical (IHC) examination was performed to determine the primary tumor, with a positive result for CK7. The diagnosis of thymic carcinoma was established based on the results of enhanced chest CT-scan and immunohistochemistry on lymph node biopsies. The patient was treated with a chemotherapy regimen of cyclophosphamide, doxorubicin, and carboplatin scheduled for six cycles. However, the patient did not survive his third cycle of chemotherapy. Establishing the diagnosis and managing CM are challenging for clinicians. This requires careful historical and physical examination, supported by histopathological examination and specific immunohistochemical marker in accordance with the suspected tumor.
format Online
Article
Text
id pubmed-9207123
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-92071232022-06-21 Cutaneous Metastases from Thymic Carcinoma Primary Tumor: A Rare Case Sutedja, Eva Krishna Rizqandaru, Trustia Ruchiatan, Kartika Sutedja, Endang Int Med Case Rep J Case Report Cutaneous metastases (CM) are neoplastic lesions of the skin originating from a primary tumor elsewhere. CM originating from primary thymic carcinoma is rare, and its incidence remains uncertain. A case of CM from thymic carcinoma in a 57-year-old man was reported. The patient complained about lumps on the skin of the chest, right shoulder and neck that appeared eleven months before the diagnosis of thymic carcinoma was established. Physical examination revealed tumors on the chest, right shoulder and neck. Histopathological examination results were consistent with CM. An immunohistochemical (IHC) examination was performed to determine the primary tumor, with a positive result for CK7. The diagnosis of thymic carcinoma was established based on the results of enhanced chest CT-scan and immunohistochemistry on lymph node biopsies. The patient was treated with a chemotherapy regimen of cyclophosphamide, doxorubicin, and carboplatin scheduled for six cycles. However, the patient did not survive his third cycle of chemotherapy. Establishing the diagnosis and managing CM are challenging for clinicians. This requires careful historical and physical examination, supported by histopathological examination and specific immunohistochemical marker in accordance with the suspected tumor. Dove 2022-06-15 /pmc/articles/PMC9207123/ /pubmed/35734095 http://dx.doi.org/10.2147/IMCRJ.S369726 Text en © 2022 Sutedja et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Case Report
Sutedja, Eva Krishna
Rizqandaru, Trustia
Ruchiatan, Kartika
Sutedja, Endang
Cutaneous Metastases from Thymic Carcinoma Primary Tumor: A Rare Case
title Cutaneous Metastases from Thymic Carcinoma Primary Tumor: A Rare Case
title_full Cutaneous Metastases from Thymic Carcinoma Primary Tumor: A Rare Case
title_fullStr Cutaneous Metastases from Thymic Carcinoma Primary Tumor: A Rare Case
title_full_unstemmed Cutaneous Metastases from Thymic Carcinoma Primary Tumor: A Rare Case
title_short Cutaneous Metastases from Thymic Carcinoma Primary Tumor: A Rare Case
title_sort cutaneous metastases from thymic carcinoma primary tumor: a rare case
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207123/
https://www.ncbi.nlm.nih.gov/pubmed/35734095
http://dx.doi.org/10.2147/IMCRJ.S369726
work_keys_str_mv AT sutedjaevakrishna cutaneousmetastasesfromthymiccarcinomaprimarytumorararecase
AT rizqandarutrustia cutaneousmetastasesfromthymiccarcinomaprimarytumorararecase
AT ruchiatankartika cutaneousmetastasesfromthymiccarcinomaprimarytumorararecase
AT sutedjaendang cutaneousmetastasesfromthymiccarcinomaprimarytumorararecase